Comments
Rossari Biotech, a speciality chemicals company, has acquired Tristar Intermediates for an enterprise value of ₹120 crore.
As per the agreement signed, Rossari will initially acquire 76 per cent equity and the balance stake over the next three years.
Rossari plans to fund the deal entirely through internal accruals, the company said. The blend of capabilities will add scale, provide cross-selling opportunities, and accelerate growth for Rossari, while significantly enhancing value creation in the longer term, it said.
The synergistic acquisition provides Rossari with enhanced portfolio of products, presence in new and untapped international markets and access to newer technologies.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.